Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$23.12 - $29.91 $640,424 - $828,507
-27,700 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$14.69 - $42.57 $36,725 - $106,425
-2,500 Reduced 8.28%
27,700 $712,000
Q4 2020

Feb 02, 2021

SELL
$12.88 - $19.47 $7,728 - $11,682
-600 Reduced 1.95%
30,200 $573,000
Q3 2020

Nov 05, 2020

BUY
$9.83 - $13.99 $31,456 - $44,768
3,200 Added 11.59%
30,800 $388,000
Q2 2020

Aug 12, 2020

BUY
$6.75 - $12.89 $98,212 - $187,549
14,550 Added 111.49%
27,600 $334,000
Q4 2019

Jan 27, 2020

BUY
$10.31 - $17.81 $134,545 - $232,420
13,050 New
13,050 $232,000
Q3 2019

Oct 31, 2019

SELL
$11.6 - $21.67 $117,774 - $220,015
-10,153 Closed
0 $0
Q2 2019

Aug 15, 2019

BUY
$18.44 - $30.89 $187,221 - $313,626
10,153 New
10,153 $225,000

Others Institutions Holding KALV

About KalVista Pharmaceuticals, Inc.


  • Ticker KALV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,602,000
  • Market Cap $226M
  • Description
  • KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...
More about KALV
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.